Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the liver toxicity in HIV-infected patients with
chronic hepatitis B and/or hepatitis C, who start a new antiretroviral drug regimen, as well
as the influence of the degree of pre-existing liver fibrosis on the incidence of liver
toxicity.
Details
Lead Sponsor:
Valme University Hospital
Collaborators:
Complejo Hospitalario de Especialidades Juan Ramón Jimenez Hospital de la Línea de la Concepción Hospital Poniente Hospital Torrecárdenas Hospital Universitario Reina Sofia Hospital Universitario Reina Sofia de Cordoba Hospital Universitario Virgen de la Victoria Hospital Universitario Virgen Macarena